mk 0663 has been researched along with Cancer of Colon in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghanghas, P; Jain, S; Rana, C; Sanyal, SN | 2 |
Kaur, J; Saini, MK; Sanyal, SN; Sharma, P | 1 |
Sanyal, SN; Tanwar, L; Vaish, V | 2 |
Piplani, H; Sanyal, S; Tanwar, L | 1 |
6 other study(ies) available for mk 0663 and Cancer of Colon
Article | Year |
---|---|
Role of GSK-3β in Regulation of Canonical Wnt/β-catenin Signaling and PI3-K/Akt Oncogenic Pathway in Colon Cancer.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Apoptosis; Celecoxib; Cell Transformation, Neoplastic; Colon; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Glycogen Synthase Kinase 3 beta; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Rats, Sprague-Dawley; Sulfones; Time Factors; Wnt Signaling Pathway | 2017 |
Chemoprevention of Colon Cancer through Inhibition of Angiogenesis and Induction of Apoptosis by Nonsteroidal Anti-Inflammatory Drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Celecoxib; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Neovascularization, Pathologic; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones | 2016 |
The cyclooxygenase-2 inhibitor etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model.
Topics: 1,2-Dimethylhydrazine; Adenoma; Animals; Anticarcinogenic Agents; Apoptosis; Biomarkers; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Etoricoxib; Immunohistochemistry; In Situ Nick-End Labeling; Male; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones | 2009 |
Chemoprevention of 1,2-dimethylhydrazine-induced colon carcinogenesis by a non-steroidal anti-inflammatory drug, etoricoxib, in rats: inhibition of nuclear factor kappaB.
Topics: 1,2-Dimethylhydrazine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Chemoprevention; Colonic Neoplasms; Etoricoxib; Immunohistochemistry; Male; Microscopy, Fluorescence; NF-kappa B; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones | 2009 |
Chemopreventive role of etoricoxib (MK-0663) in experimental colon cancer: induction of mitochondrial proapoptotic factors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Colonic Neoplasms; Cytochromes c; Etoricoxib; Genes, bcl-2; Intestinal Mucosa; Male; Membrane Potential, Mitochondrial; Mitochondria; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones | 2010 |
Anti-proliferative and apoptotic effects of etoricoxib, a selective COX-2 inhibitor, on 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Colon; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; DNA Fragmentation; Etoricoxib; Male; Proliferating Cell Nuclear Antigen; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones | 2010 |